Jun 3, 2024, 06:39
Andrea Necchi: MTAP loss be a potentially novel synthetic lethality target in 24% urothelial cancers
Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X/Twitter:
“By analyzing 540K pantumor samples we highlighted MTAP loss be a potentially novel synthetic lethality target in 24% urothelial cancers. Definitely worth considering for the next trial designs | Huge congrats to my team and the unique Jeff Ross.”
Source: Andrea Necchi/X